Hi W3. First let me say that I really appreciate your contribution to the forum. Thanks. I have one question. You have mentioned a number of times that RAC has no earnings. While that is true I contend that RAC is somewhat unique among junior speccy biotechs for 2 reasons. The first is that RAC has significant assets. Those are the large number of successful clinical trial results that would cost many millions of dollars to replicate by another biotech with a new compound. The second reason is that we know our compound works. (See reason 1). We are also fully funded through 2021, a time period where it is highly probable that a significant revenue event occurs. Forgive my TA ignorance but does what I have outlined above come into your thinking? Cheers.
Hi W3. First let me say that I really appreciate your...
-
- There are more pages in this discussion • 18,944 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.70 |
Change
0.090(5.59%) |
Mkt cap ! $289.5M | |||
| Open | High | Low | Value | Volume |
| $1.60 | $1.76 | $1.59 | $142.7K | 84.97K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 17175 | $1.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.77 | 6060 | 1 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |